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Murine T lymphocytes (responder cells) when cocultivated in the mixed lymphocyte
culture (MLC' together with H-2 incompatible lymphocytes (stimulator cells) undergo a
phase of cell proliferation which ultimately culminates in the generation of cytotoxic T
lymphocytes (CTL) (1-4) . Recent results obtained with inbred strains carrying intraH-2-
recombinant chromosomes suggest that the cytotoxic activity of the CTL generated is
directed against products coded by the H-2K or H-2D region of the H-2 complex (i .e .
serologically defined [SDI H-2 private specificities, or products closely linked to them) (5-
7) . In contrast antigens coded by the I region of the H-2 complex effectively induce
proliferative responses in the MLC, yet appear not to be recognized as target by the CTL
generated (6-12) .
The view of functional differences between peripheral (H2D and H-2K) re-
gions and the central (I) region of theH-2 complex has recently been challenged
by the observation that I-region-different mice carrying no known histocompat-
ibility differences nevertheless reject each others' skin graft (13-15) . Moreover
cytotoxic lymphocytes were detected in the spleen of mice immunized with skin
grafts from I-region-incompatible mice (16) . These paradoxical findings
prompted us to reinvestigate the genetic requirements for the in vitro induction
of CTL . We now report that products coded by the I region of theH2 complex
are capable to trigger in vitro the generation ofCTL .
Materials and Methods
Animals .
￿
All mice were used at an age ofbetween 6 to 10wk . C57BL/lOSn(B10), BlO.D2/nSn,
B10.BR/SgSn, B10.A/SgSn, B10.A(2R)/SgSn, B10.AKM/Sn, DBA/2J, DBA/1J, A/J, and A.SW/sn
were purchased from Jackson Laboratories, Bar Harbor, Maine . A.TL, A.TH, BlO.HTT, and
B10.A(4R) mice were originally provided by DoctorsD . C . Shreffler and C . S . David, University of
Michigan, Ann Arbor, Michigan, and now maintained in our colony . The former was obtained
from Dr . Holmes, Melbourne, Australia, the latter strain was kindly provided by Dr . J . Klein,
University of Texas, Southwestern Medical School, Dallas, Texas, when it was in the fifth
backcross generation to B10 . In this study F4 of the N5 homozygous backcross were used . All
hybrids used in this study were produced in our laboratory . The genetics of the strains regarding
* This work was supported by the SFB 107 (Mainz) and the SFB 37 (Miinchen) ofthe Deutsche
Forschungsgemeinschaft .
' Abbreviations used in this paper: Con A, concanavalin A ; CTL, cytotoxic T lymphocytes ;
DMEM, Dulbecco's modified Eagle's medium ; LPS, lipopolysaccharide ; ME, mercaptoethanol ;
MLC, mixed lymphocyte culture ; PHA, phytohemagglutinin .
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their H-2 haplotype are indicated in terms of the allelic origin of the K, I-A, I-B, I-C, S, andD
regions, respectively (Table I) .
Antisera .
￿
Antiserum to theta alloantigen of C3H mice (anti-Thy 1.2) was raised as reported
(17) and used in the complement (C)-dependent cytotoxicity assay (treatment with anti-Thy 1 .2
serum and C) as described (17) .
Separation by Velocity Sedimentation at 1 g .
￿
The technique of Miller and Phillips (18) in the
modification ofMcDonald et al . (19) was used . Mitogen-stimulated cells out ofwhich the blast cells
had to be separated, were harvested from the culture, applied (150 x 108 cells) to the gradient
consisting of 7-30% horse serum in phosphate-buffered saline, and allowed to sediment for 4 h at
4°C . Blast cells sedimenting faster than 4.5 mm/h (20) were pooled and used as target cells .
In Vivo Immunization .
￿
Mice were immunized by skin grafting (sex identical animals) followed
1 wk later by intraperitoneal injection of 15 x 10 8 splenic lymphocytes of skin donor origin . The
skin-grafting technique employed was described by Klein and Bailey (21) . 4wk after grafting the
spleen cells of the mice were used as responder cells and re-exposed in a "secondary" MLC to the
same allogeneic stimulus .
Mixed Lymphocyte Culture .
￿
Spleen cells of the various strains were used as source of respond-
ing and stimulating cells. Before culture, the stimulating cells received a dose of 3,000 rads
(Philips machine RT 200) at a dose rate of 620 rads/min . The cells were prepared as described (22)
and cultured in multi-dish culture trays (Linbro FB-24Tc, Linbro Chemicals, New Haven, Conn.)
using Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 mM HEPES, 2 x 10-5
M mercaptoethanol (ME), and 5% fetal calf serum (20) . Splenic responder cells (4 x 108) and
stimulator cells (1.5 x 108) were cultured in a vol of 2 ml (20) in a humified atmosphere of 10% CO z
in air for the desired period of time . At the end of the incubation period, the cells were collected,
washed, resuspended to 5 x 10 5 viable cells/ml (as determined by eosin dye exclusion), and tested-
for cytotoxic activity .
Target Cells . Phytohemagglutinin (PHA)-, lipopolysaccharide (LPS)-, and concanavalin A
(Con A)-transformed lymphoblasts were used as target cells . In selected experiments only target
cells purified according to their sedimentation rate at 1 g (see above) were used . Lymphoblasts
were obtained by pooling replicate cultures containing 5 x 108 spleen cells which had been
cultured for 72 h in DMEM (without ME) containing either PHA-M(no . R 15-0576, Grand Island
Biological Co ., Grand Island, N . Y .) at a final dilution of 1:500, or 5 Wg/ml LPS (Difco Laboratories,
Detroit, Mich .), or 5 Wg/ml Con A (Pharmacia Fine Chemicals, Inc ., Uppsala, Sweden) . Usually
3-5 x 108 blast cells were labeled with 150 EACi 5'Cr (Radio Chemical Centre Amersham, Buchler,
Frankfurt, Germany) as described (22) .
Cytotoxicity Assay .
￿
Various numbers of viable MLC cells were incubated with a constant
number (2 x 1(N) s'Cr-labeled target cells . Percent specific 5'Cr release was calculated as described
(23) . For each lymphocyte population tested a dose response curve was established . The SD of
triplicate assays was calculated . The data are given without SD since in all experiments listed the
SD of percent lysis was less than 5% .
Results
Secondary In Vitro Cytotoxic Responses against Products Coded by Subre-
gions of the H-2 Complex . Spleen cells of mice immunized in vivo against
alloantigens controlled by distinct regions of theH2 complex were cocultivated
in a"secondary"MLC together with stimulator cellswhichwereH2 identical to
the cells used for in vivo immunization . After 5 days of culture the responder
cells were tested for cytotoxic activity against S 1Cr-labeled LPS-induced blast
lymphocytes . Representative results obtained are given in Table II and clearly
suggest that cytotoxic activity was detectable against determinants controlled
by either theH-2K, H-2D, or the I region . No cytotoxic activity was observed
against products coded by theI-B or I-C subregion . In these strain combinations
the skin grafts were not rejected within 25 wk (Table II) .
Primary In Vitro Cytotoxic Responses against Products Coded by the I Re-
gion .
￿
Representative results obtained in a primaryMLC are listed in Table IIIH . WAGNER, D. GUTZE, L. PTSCHELINZEW, AND M. ROLLINGHOFF 1479
TABLE I
H-2 Haplotype ofthe Mice Used
The data are derived from reference 11 .
and demonstrate that cytotoxic effector cells against I-region-coded determi-
nants can be inducedin vitro. In five combinations differing fortheI-A andI-B,
or the former and the I-C region, CTL cells were generated. Since there is no
combination available to investigate the effect of a separate I-A subregion
difference we attempted tentatively to map by exclusion the1 subregion control-
ling the target antigen for CTL. Thus, A.TH cells stimulated by A.TL were
tested for their ability to lyse cells identical with the stimulator for the wholeI
region (A.TL), for the I-A and I-B subregions (AQR), or the I-A subregion
[B10.A(4R)]. In each instance a comparable lysis was observed. It appears
thereforethatthe1-A subregioncontrolled the maintarget ofthe CTL generated
in this combination. This conclusion is strengthened by the negative results
obtained with combinations differing for the I-B or I-C region only [the latter
one might not be a complete but only partial difference, since theI-C region of
theH-2dandH2khaplotype are either cross-reactive orpartially identical (24)].
In two combinations, i.e. the (DBA/1 x B10.D2)F, anti-AQR and the A.TH
anti-A.TL combination, besides the indicated I-region difference (Tables II and
III) there exists an additional difference at the Ma locus (25, 26). To diminish
the probability that products of this locus represent the target antigens of the
CTL generated in these combinations, A.TH (Maa) effector cells generated
againstA.TL (Me) were tested againsttarget cellsdiffering with respect to the
TLa allele from A.TL, namely AQR (Maa) and B10.A(4R) (TLab) cells. The
observed almost equal lysis of LPS blasts derived from these strains make it
improbable, although do not rule out, that TLa-gene products are the target
antigens.
It should be noted that the data reported in Tables II and III represent a
summary ofseveral independent experiments performedover a time period of4
mo. Therefore it is not possible to compare the magnitude ofcytotoxic responses
Strain
K
H-2
I-A
haplotype
I-B
(allelic
I-C
origin)'
S D
AQR q k k d d d
B10.HTT $ s s k k d
B10.A k k k d d d
B10.A(4R) k k b b b b
B10.A(2R) k k k d d b
A.TH s s s s s d
A.TL s k k k k d
B10.BR k k k k k k
A/J k k k d d d
B10 b b b b b b
MOM d d d d d d
C57BL/6 b b b b b b
A.SW s s s s s s
CBA k k k k k k
DBA/1 q q q q q q1480
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TABLE II
Secondary Cytotoxic In Vitro Responses against Products Coded by Various Regions of
the H-2 Complex
"Cr release assay
Mice were first immunized in vivo by skin grafting followed by intraperitoneal injection of 15 x
108 splenic lymphocytes. After 4 wk, the spleen cells were used as responder cells and cultured
togehter with stimulator cells carrying the same H-2 haplotype against which the responder
cells have been immunized. After 5 days ofculture the responder cells were tested for cytotoxic
activity against various "Cr-labeled LPS-induced blast lymphocytes. Background lysis of the
LPS blast cells ranged between 18-32%. The strain combinations listed were tested at least three
times. Representative experiments are given.
* Skin graft rejected after 2 wk.
f Skin graft not rejected after 25 wk .
obtained across the experiments listed. For example, the cell combinationA.TH
anti-A.TL (Table III) was tested seven times. In five experiments the cytotoxic
activity obtained ranged between 24-53% lysis (at a ratio of30:1), and in two of
the experiments no significant cytotoxic activity was detectable.
Lytic Activity ofI-Region-Induced CTL againstLPS, ConA, andPHA Target
Cells. Next it was tested whethercytotoxic lymphocytesgenerated inI-region-
stimulatedMLC's are equally cytotoxicfor LPS-, ConA-, andPHA-induced blast
lymphocytes. In order to ensure that the results obtained are not obscured by
contamination with the heterogeneous population of small lymphocytes, only
blast cells purified by velocity sedimentation at 1 g were used as target cells.
The results obtained (Table IV) clearly suggest that I-region-induced cytotoxic
lymphocytes were equally cytotoxic for LPS and ConA blast cells, but barely for
PHA blasts.
"Immune" responder
cells
Stimulator
cells
Stimulating
H-2 region
Origin of
LPS-induced
target cells
% Specific
ratio
effector
target
30:1
lysis
of
cells to
cells
3:1
(DBA/1 x Bi0.D2)F,* AQR I-A, I-B AQR 73 34
B10.A 54 25
B10.D2 2 0
(A.TL x B10.D2)F,* B10.HTT I-A, I-B B10.HTT 64 29
A.TH 48 21
A.TL 3 1
(B10.A(4R) x DBA/2)F,f B10.A I-B B10.A 4 1
(CBA x B10W,$ B10.A(2R) I-C B10.A(2R) -2 0
(A.SW x B10.A)F,$ A.TL I-C, S A.TL 0 -3
(A.TL x B10.D/2)F,* B10.BR K, D B10.BR 84 47
A.TH 5 1
(A.TL x B10.D/2)F,* A/J K A/J 66 44
(ASW x CBA)F,* ATL D ATL 87 66H . WAGNER, D . GOTZE, L . PTSCHELINZEW, AND M . ROLLINGHOFF
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TABLE III
Primary Cytotoxic In Vitro Responses against Products Coded by Regions of theHZ
Complex
5'Cr release assay
Responder and stimulator were cultured in a MLC over 5 days . Cytotoxic activity generated was
tested against LPS-induced blast lymphocytes (target cells) at various ratios of lymphocytes to
target cells . Background lysis of the target cells was less than 29% . Each cell combination was
tested at least three times . Representative experiments are given .
That the cytotoxic lymphocytes generated in an I-region-stimulated MLC
were T cells in type, was suggestedby the fact that pretreatment with anti-Thy
1.2 serum plus C abolished their cytotoxic activity (Table V) .
Attempts to Compare the Relative Stimulating Capacity ofDifferentRegions
of theH2 Complex . The relative stimulating capacity ofthe central I region
and the peripheral K andD regions was compared to that of the completeH2
complex. Equal numbers of (A.TL x B10.D2)F, cells (responder cells) were
cultured under identical conditions together with splenic stimulator cells de-
rived from either B10.HTT mice (I-A- and I-B-subregion stimulation), or from
B10.BR mice (D- andK-region stimulation) or from C57BL/6 mice (H-2b complex
stimulation) . After 5 days the cultured cells were harvested and tested for
cytotoxic activity against both PHA- and LPS-induced blast lymphocytes. The
results (Fig . 1) demonstrate that the anti-H2b complex response resulted in the
strongest cytotoxic activity . Moreover CTL generated in the anti-H-2 complex
Responder cells
Stimulator
cells
Stimulating
H-2 region Origin of
LPS-induced
target cells
% Specific
ratio
effector
target
30 :1
lysis
of
cells to
cells
3 :1
(DBA/1 x B10.D2)F, AQR I-A, I-B AQR 47 21
B10.D2 5 0
(A.TL x B10.D2)F, B10.HTT I-A, I-B B10.HTT 32 15
B10.BR -1 0
A.TH A.TL I + S A.TL 38 17
AQR 42 11
B10.A(4R) 34 12
A.TH 2 0
A.TL B10.HTT 1-A, I-B B10.HTT 23 11
(A.SW x B10.D2)F, A.TL I + S A.TL 44 19
(B10.ARR) x DBA/2)F, B10.A I-B B10.A 5 1
(A.SW x B10.A)F, A.TL I-C, S A.TL 0 -4
(CBA x B10)F, B10.A(2R) 1-C, S B10.A(2R) 1 -3
(A.TL x B10.D2)F, A/J K A/J 27 14
(A.SW x CBA)F, A.TL D A.TL 31 19
(A.TL x B10.D2)F, B10.BR K, D B10.BR 40 221482
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TABLE IV
Lytic Activity ofI-Region-Induced CTL against PHA-, LPS-, and Con
A-Induced Blast Cells
A.TH or (A.SW x B10.D2)F, mouse-derived responder cells were cultured
together with A.TL mouse-derived stimulator cells (I-region stimulation).
After 5 days the responder cells generated were tested for cytotoxic activity
against purified (velocity sedimentation at 1g) LPS-, Con A-, or PHA-induced
A.TL-derived blast lymphocytes. Background lysis of the A.TL target cells
was: LPS blasts, 24%, Con A blasts, 27% and PHA blasts, 32%.
response lysed LPS and PHA blast almost equallywell, thisbeing in agreement
with previous work (27). Ifone compared the ratio ofeffector cells to target cells
required to achieve 50% lysis ofthe target cells, the cytotoxic activity'triggered
by the H-21' complex incompatibility was about 30-fold stronger than that
induced by a mere D- and K-region stimulation. Compared to the cytotoxic
activity inducedbyI-A- andI-B-subregionstimulationthe magnitudeofcytotox-
icity ofthe antiH-2° complex response was about 40-fold stronger. This conclu-
sion is based onthe assumption thatallthe LPS target cellsused carry the same
amount of1-region-coded target antigens.
Discussion
A strong argument infavor ofthe presentlyheld viewoffunctional differences
betweenthe peripheral KandD regions (7, 9, 12) andthe centralI region (5-7, 9,
12) of the H2 complex represents the observation that in the presence of I-
region-incompatible stimulator cells the cytotoxic response generated in a MLC
againstD- and/or K-region-incompatible cells becomes amplified (22, 28-30). On
the basis ofthese findings Schendel and Bach (22) and we (31) proposed the "two
signal" hypothesis . Accordingly theI region is primarilyinvolved in lymphocyte
activation as detected by thymidine uptake techniques in the MLC. In contrast
the peripheral regions code for serologically detectable (SD) transplantation
antigens which function as target forthe CTL generated. On the other hand the
observation that I-region-incompatible mice reject each others' skin graft (13, 14)
and generate cytotoxiclymphocytes (16), led tothepostulate thatI-region-coded
determinants (Ia antigens) also function as transplantation antigens.
s'Cr release assay
Mitogen
Stimulator
Responder cells used for % Specific lysis
cells
AM blast
target cell 30:1 3:1
induction
A.TH A.TL LPS 47 22
Con A 32 15
PHA 9 3
(A.SW x B10.D2)F, A.TL LPS 21 12
Con A 18 5
PHA 6 1H . WAGNER, D . GUTZE, L . PTSCHELINZEW, AND M . ROLLINGHOFF
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TABLE V
Susceptibility ofCytotoxic Lymphocytes Generated against I-
Region-Coded Determinants to Treatment with anti-Thy 1 .2
Serum Plus C
Specific lysis
Treatment with
No treatment
￿
anti-Thy 1.2 serum
plus C
Treatment with
AKR serum plus C
(DBA/1 x B10.D2)F, splenic lymphocytes (responder cells) were cul-
tured in a MLC with AQR mouse-derived splenic stimulator cells for 5
days . The cells were harvested and divided into three parts . One cell
fraction remained untreated, one was treated with anti Thy 1.2 serum
plus C (17), and the third fraction was treated with normal AKR serum
plus C . The cell fractions were tested for cytotoxicity against LPS-
induced AQR blast cells at that cell dilution, which resulted in the case
of untreated cells in a ratio ofviable lymphocytes to target cells of 30 to
1 . Background lysis of target cells was 28% .
So far the lytic activity ofCTL generated in aMLChas been tested mostly on
PHA-stimulated lymphoblasttargets (5-7). Yetla antigens appear to bepredom-
inantly expressed on B cells (27, 32-35) . Therefore in the present experiments
LPS-induced blast cells (B-cell derived) were used as targets for detecting I-
region-induced CTL. Moreover since the magnitude ofcytotoxic activity induced
in a secondary MLC exceeds that of a primary MLC (36, 37), it was concluded
that by first immunizing mice in vivo against I-region-coded determinants it
may be possible to generate CTL against these determinants in a subsequent
MLC. Indeed, when using preimmunized responder cells strong lytic activity
was triggered against I-A, I-B incompatible stimulator cells, provided LPS
blast lymphocytes were used as targets (Table II) . These results agreed with the
finding that I-A, I-B incompatibility also resulted in skin graft rejection (Table
II, andD. Gotze, unpublished results) . However no significant cytotoxic activity
was detected against I-B- and I-C-coded determinants (these mouse combina-
tions also failed to induce skin graft rejection) . Essentially identical results were
obtained in primary MLC's, although the magnitude of cytotoxic responses
induced was reduced . Thus I-region- or I-A, I-B-subregion incompatibility in-
duced lytic activity, whereas I-B- and I-C-subregion differences failed to do so
under the experimental conditions used . I-region-coded determinants were rec-
ognized equally well on LPS- and Con A-induced lymphoblasts, but to a much
lower extent on purified PHA blast cells (Table IV). These results may explain
the previous failure to detect CTL in a I-region-stimulated MLC using PHA
blast lymphocytes as targets (7, 9) . While both K/D-region andI-region incom-
patibility triggered the generation of specific CTL in vitro (Tables 2 and 3), the
magnitudeof cytotoxic responsesinducedby completeH-2-complex incompatibil-
ityexceeded by far thesum of the individual responses againsttheH-2K,H-2D,
and I region, respectively (Fig . 1) . Although the interpretation ofthese results is
limited by the fact that the stimulator cells used were incompatible to the1484
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FIG. 1 . (A.TL x B10.D2)F, spleniclymphocytes(responder cells) were stimulated in aMLC
against either C57BL/6 (H-2° complex stimulation), or B10.BR(K,D region stimulation) or
B10.HTT (I-A, I-B subregion stimulation) mouse derived splenic stimulator cells . After 5
days of culture the responder cells were titrated for cytotoxic activity against purified
(sedimentation velocity technique at 1 g) LPS and PHA-induced blast cells carrying the
sameH-2 haplotypeagainstwhichtheresponder cellswere immunized. Background lysis of
the target cells was less than 30%. C57BL/6 (O) PHA blasts and (")LPS blasts ; B10.BR (0)
PHAblasts and (") LPS blasts ; and B10.HTT (A)PHA blasts (A) LPSblasts .
responder cells atH-2 regions of different H-2 haplotypes, the results neverthe-
less are suggestive for a helper effect of an I-region incompatibility upon the
generation of CTL reactive to K- and D-region-coded determinants (22, 27-30) .
Theseresultscomplement independent evidence that adistinct T-cell subpopula-
tion (T, cells), which can be characterized by functional (38), physical (39), and
serological criterias (40), and which appears to be preferentially reactive to I-
region-coded MLC determinants (40), exerts an amplifying effect on the induc-
tion of CTL reactive against H-2K- and H-2D-coded antigens .
The data presented here allow no answer in regard to the critical question
whetherI-region-coded determinants as detectedby CTL are identical to either
the MLC-stimulating determinants or to the serologically detectable Ia anti-
gens . If it turns out that each determinant coded by the I region, which can be
serologically detected, also is capable to provoke both cell proliferation and the
generation ofCTL in aMLC (alternative A, Fig . 2), then there is no necessity to
postulate functional differences between peripheral and central regions of the
H-2 complex during the induction ofa primaryMLC. If, however, MLC-stimulat-
ing determinants are qualitatively different from target antigens recognized by
CTL and if the recent evidence for T,-T2 cell synergism (39, 40) during allogeneic
cell interactions is further substantiated, then the data presented here may be
viewed as given in alternative B (Fig . 2) . Accordingly, a thirdmurine histocom-
patibility locus (H2I) is situated in the I-A region. ThisH locus also has been
detected by skin grafting (16) . Since loci within the I-A, I-B, and I-C are
controlling both MLC determinants and histocompatibility antigens the postu-
latedH-2I locus within theI-A subregion at present is not separable from those
controllingMLC determinants . The observationthat certainMLC determinants
fail to trigger CTL, (Tables II and III, and reference 20) yet provide a helperH. WAGNER, D. GOTZE, L. PTSCHELINZEW, AND M. RULLINGHOFF 1485
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effect upon the generation of CTL reactive to K- and D-region-coded determi-
nants (41), however, provides additional support for the view of functional
differences (alternative B) between MLC determinants and determinants for
CTL in allogeneic lymphocyte interactions.
Summary
Determinants controlled by theI region of the murine H-2 complex provoked
the generation of cytotoxic T lymphocytes (CTL) in both a secondary and
primary mixed lymphocyte culture. The stimulating determinants appeared to
be controlled by loci within theI-A subregion. The target antigens of the CTL
generated were present on both lipopolysaccharide- and concanavalin-induced
blast lymphocytes, but were barely detectable on phytohemagglutinin-induced
blast cells. The stimulating capacity for CTL induction of a complete H2
complex incompatibility by far exceeded the sum ofH2D/K-region andI-region
incompatibility, respectively.
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